LigoCyte Pharmaceuticals, Inc.

18 articles about LigoCyte Pharmaceuticals, Inc.

• Takeda Pharmaceutical Co. Ltd. Pays $60 Million for LigoCyte Pharmaceuticals, Inc.

  10/5/2012

• The New England Journal of Medicine Publishes Study Showing LigoCyte Pharmaceuticals, Inc.'s Norovirus Vaccine Demonstrates Protection Against Illness

  12/8/2011

• LigoCyte Pharmaceuticals, Inc. Looks to Build Manufacturing Facility in Bozeman; Could Potentially Bring Hundreds of Jobs Over the Next Couple of Years

  3/30/2011

• Positive Results From LigoCyte Pharmaceuticals, Inc.'s Norovirus Vaccine Challenge Study

  10/25/2010

• LigoCyte Pharmaceuticals, Inc. Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine

  9/16/2010

• Data From LigoCyte Pharmaceuticals, Inc.'s Clinical Studies of Norovirus VLP Vaccine Presented at 13th Annual Conference on Vaccine Research

  4/28/2010

• LigoCyte Pharmaceuticals, Inc. Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge

  9/8/2009

• PacificGMP and LigoCyte Pharmaceuticals, Inc. Announce cGMP Manufacturing Collaboration

  2/9/2009

• LigoCyte Pharmaceuticals, Inc. Finalizes Agreement for $28M Series 'C' Financing Round

  3/18/2008

• LigoCyte Pharmaceuticals, Inc. Announces Collaboration With Biogen Idec, Inc. (Massachusetts) to Develop Anti-CD103 Therapies

  9/18/2007

• LigoCyte Pharmaceuticals, Inc. Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization

  5/2/2007

• LigoCyte Pharmaceuticals, Inc. Initiates U.S. Clinical Trial of Norovirus Vaccine

  4/3/2007

• Donald P. Beeman Is Appointed Chairman Of The Board Of Directors At LigoCyte Pharmaceuticals, Inc.

  1/3/2007

• LigoCyte Pharmaceuticals, Inc. Announces The Addition Of Dr. Donald deBethizy To Their Board Of Directors

  12/14/2006

• LigoCyte Awarded An Additional $2.3M Department Of Defense Contract To Continue The Preclinical Development Of Their 3rd Generation, Mucosal Anthrax Vaccine

  7/6/2006

• LigoCyte Pharmaceuticals, Inc. Welcomes Don Beeman As New CEO

  5/18/2006

• LigoCyte Presents Data Showing Protection From Improved Anthrax Vaccine At The ASM Biodefense Meeting

  3/22/2005

• LigoCyte Pharmaceuticals, Inc. Awarded Additional $2.1M Department Of Defense Contract For The Development Of Norovirus Vaccines And Therapeutics

  6/25/2004